Restrata Wound Matrix
Payment Trends by Year
| Year | Amount | Transactions | Doctors |
|---|---|---|---|
| 2024 | $847,222 | 4,241 | 2,922 |
| 2023 | $1.1M | 2,692 | 1,734 |
| 2022 | $352,470 | 2,555 | 1,627 |
| 2021 | $279,551 | 1,412 | 846 |
| 2020 | $115,816 | 606 | 401 |
| 2019 | $38,463 | 1,129 | 819 |
| 2018 | $261,103 | 60 | 27 |
| 2017 | $570.44 | 10 | 5 |
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Unspecified | $1.4M | 139 | 47.8% |
| Food and Beverage | $601,281 | 12,153 | 19.9% |
| Debt forgiveness | $591,247 | 103 | 19.5% |
| Consulting Fee | $330,210 | 136 | 10.9% |
| Travel and Lodging | $52,395 | 166 | 1.7% |
| Education | $6,534 | 8 | 0.2% |
Payments by Type
Research Studies & Clinical Trials
| Study Name | Sponsor | Amount | Doctors |
|---|---|---|---|
| Assessment of Wound Closure Comparing Synthetic Hybrid- Scale Fiber Matrix with Lyophilized Acellular Fish Skin in Treating Diabetic Foot Ulcers (DFU) and with Living Cellular Skin Substitute in Treating Venous Leg Ulcers (VLU) | Acera Surgical, Inc. | $821,807 | 0 |
| Restrata study on Wound Care | Acera Surgical, Inc. | $250,818 | 3 |
| Retrospective Wound Care Case Series | Acera Surgical, Inc. | $170,982 | 16 |
| Assessment of Wound Closure Comparing Synthetic Hybrid-ScaleFiber Matrix with Standard of Care in Treating Diabetic Foot Ulcer | Acera Surgical, Inc. | $115,750 | 0 |
| Assessment of Wound Closure Comparing Synthetic Hybrid-Scale Fiber Matrix With Standard of Care in Treating Diabetic Foot Ulcer | Acera Surgical, Inc. | $51,896 | 0 |
| Randomized Clinical Trial to Compare Restrata and Negative Pressure Wound Therapy (NPWT) to Heal Complex Diabetic Foot Wounds | Acera Surgical, Inc. | $18,980 | 0 |
| Histopathologic Analysis of a Recalcitrant Calcaneal Wound Treated Using a Synthetic Hybrid-scale Fiber Matrix | Acera Surgical, Inc. | $16,580 | 0 |
Top Doctors Receiving Payments for Restrata Wound Matrix
| Doctor | Specialty | Location | Total | Records |
|---|---|---|---|---|
| Unknown | — | Tucson, AZ | $1.1M | 95 |
| , MD | Surgical Oncology | Hialeah, FL | $111,800 | 27 |
| , DPM | Foot & Ankle Surgery | Fresno, CA | $81,300 | 4 |
| , MD | Trauma Surgery | Dallas, TX | $71,346 | 35 |
| , DPM | Podiatrist | Arlington Heights, IL | $63,149 | 45 |
| , D.P.M | Primary Podiatric Medicine | Greenacres, FL | $60,849 | 6 |
| , D.P.M | Durable Medical Equipment & Medical Supplies | Dallas, TX | $49,285 | 5 |
| , M.D | Surgery | Hialeah, FL | $42,250 | 4 |
| , DPM | Podiatrist | Phoenix, AZ | $41,016 | 3 |
| , MD | Surgery | Oak Lawn, IL | $35,207 | 10 |
| , DPM | Foot Surgery | Sunnyvale, TX | $28,382 | 11 |
| , DPM | Student in an Organized Health Care Education/Training Program | La Crosse, WI | $27,908 | 35 |
| , MD | Surgery | Philadelphia, PA | $27,810 | 4 |
| , M.D | Orthopaedic Surgery | Germantown, TN | $27,369 | 29 |
| , D.P.M | Foot & Ankle Surgery | Los Angeles, CA | $26,410 | 5 |
| , DPM | Podiatrist | Des Plaines, IL | $24,807 | 30 |
| , MD | Plastic and Reconstructive Surgery | Atlanta, GA | $22,300 | 47 |
| , DPM | Podiatrist | Deridder, LA | $22,230 | 12 |
| , MD FRCSC | Otolaryngology | North Charleston, SC | $21,572 | 34 |
| , DO | Dermatology | Jupiter, FL | $19,580 | 1 |
| , D.P.M | Foot & Ankle Surgery | Arcadia, CA | $18,514 | 11 |
| , MD | Orthopaedic Surgery | Aurora, CO | $16,763 | 3 |
| , D.P.M | Foot & Ankle Surgery | Garden Grove, CA | $16,200 | 1 |
| , M.D | Surgery | Boulder, CO | $15,531 | 18 |
| , M.D | Surgery | Chicago, IL | $15,445 | 115 |
Manufacturing Companies
- Acera Surgical, Inc. $3.0M
Product Information
- Type Device
- Total Payments $3.0M
- Total Doctors 6,726
- Transactions 12,705
About Restrata Wound Matrix
Restrata Wound Matrix is a device associated with $3.0M in payments to 6,726 healthcare providers, recorded across 12,705 transactions in the CMS Open Payments database. The primary manufacturer is Acera Surgical, Inc..
Payment data is available from 2017 to 2024. In 2024, $847,222 was paid across 4,241 transactions to 2,922 doctors.
The most common payment nature for Restrata Wound Matrix is "Unspecified" ($1.4M, 47.8% of total).
Restrata Wound Matrix is associated with 7 research studies, including "Assessment of Wound Closure Comparing Synthetic Hybrid- Scale Fiber Matrix with Lyophilized Acellular Fish Skin in Treating Diabetic Foot Ulcers (DFU) and with Living Cellular Skin Substitute in Treating Venous Leg Ulcers (VLU)" ($821,807).